Long-term results of infragenicular bypasses with autogenous vein originating from the distal superficial femoral and popliteal arteries
|
|
- Doris Bradley
- 5 years ago
- Views:
Transcription
1 Long-term results of infragenicular bypasses with autogenous vein originating from the distal superficial femoral and popliteal arteries Mark S. Rosenbloom, M.D., James J. Walsh, M.D., James J. Schuler, M.D., Joseph P. Meyer, M.D., Thomas H. Schwarcz, M.D., Jens Eldrup.Jorgensen, M.D., Joseph R. Durham, M.D., and D. Preston Flanigan, M.D., Chicago, Ill. Forty-nine bypasses originating from the distal superficial femoral artery or popliteal artery in 46 patients were reviewed to examine late patency, limb salvage, and factors leading to graft failure. Operations were performed because of tissue loss in 86%, rest pain in 12%, and limiting claudication in 2% of limbs. Proximal anastomosis was from the distal superficial femoral artery in 12% and the popliteal artery in 88%. Distal anastomosis was to the below-knee popliteal artery or proximal tibial vessels in 2% and the distal tibial vessels in 8%. Life-table analysis showed a primary patency rate of 83%, 62%, and 41%, at 1, 3, and 5 years, respectively. The rate of limb salvage at 6 years for all grafts was 69%. Cox proportional hazards analysis determined that s tenosis of 2% or greater in the proximal superficial femoral artery before bypass was a significant risk factor for graft failure (p =.2) despite the presence of normal intra-arterial pressure at the site of the proximal anastomosis at the time of bypass. Long-term survival in these patients was low, with a 6-year survival rate of only 24%. Infragenicular bypasses originating from the distal superficial femoral artery or the popliteal artery can be performed with patency and limb salvage rates comparable to bypasses originating from the common femoral artery. These bypasses are more likely to fail when performed in the presence of a stenosis 2% or greater in the superficial femoral or popliteal artery proximal to the graft origin. (J VASC SURG 1988;7:691-6.) The common femoral artery is considered the preferred site of proximal anastomosis for infragenicular bypass grafting.1 Use of the superficial femoral artery or the popliteal artery as the source of inflow for distal bypasses has been criticized because of the belief that progression of atherosclerosis in the superficial femoral artery will subsequently lead to graft failure. 2-s Access to the common femoral artery as an inflow source may be precluded by infection or by scarring from previous operations in the groin. In addition, inadequate length of the vein available for bypass may not allow the use of the common femoral artery as the origin of distal bypass grafts. Use of the profunda femoris artery for bypass inflow has also been described. 6,7 Previous reports of infragenicular bypasses originating from the distal superficial femoral and popliteal arteries have shown patency rates From the Department of Surgery, Division of Vascular Surgery, University of Illinois College of Medicine at Chicago. Presented at the Eleventh Annual Meeting, Midwestern Vascular Surgical Society, Chicago, Ill., Sept , Reprint requests: D. Preston Flanigan, M.D., Chief, Division of Vascular Surgery (m/c 957), University of Illinois at Chicago, 174 West Taylor St., Suite 22, Chicago, IL of 7% to 8% and limb salvage rates of 7% to 9% at 3 to 6 years. 8~ This article examines the late patency and limb salvage for infragenicular bypasses pcrformed with autogenous vein grafts that originated from the distal superficial femoral or popliteal arteries and serves to update our earlier report on these bypasses. 9 In addition, the factors leading to graft failure, in particular progrcssion of superficial femoral artcry disease, will be assessed. MATERIAL AND METHODS All patients having infragenicular bypasses with autogenous vein grafts that originated from the distal superficial femoral or popliteal arteries at the University of Illinois, Cook County, and West Side Veterans Administration Hospitals between 1979 and 1986 were included in the study. Hospital charts, operative records, and noninvasive vascular laboratory charts from before and after operation were reviewed. Preoperative and operative arteriograms were studied so that ~he arterial runoff for each bypass could be determined as described by Rutherford et al. ~ Runoff scores ranged from 1, for widely patent vessels, to for blind segments. Preoperative 691
2 692 Rosenbloom et al.,yournat of VASCULAR SURGERY 9 BO?O , Og, \ I MONTHS Fig. 1. Life-table plot of primary patency for 49 infragenicular bypasses that originated from the distal superficial femoral or popliteal arteries. Number of patent grafts remaining at each interval is shown over the standard error for each interval. arteriograms were also reviewed to determine the presence of stenotic atherosclerotic disease proximal to the origin of the bypass graft. The degree of diameter reduction as measured in one plane was used to determine the amount of stenosis present. Follow-up information was obtained from recent clinic visits. Graft patency was determined by the presence of a palpable pulse in the graft on physical examination or by Doppler-derived pressure measurements in the bypassed limb. Patients without recent follow-up were contacted for reexamination. When examination was not possible, follow-up information regarding death, cause of death, and limb salvage was obtained from referring physicians, the patient, or the patient's family. In cases where recent follow-up was not possible, patency was determined at the time of the most recent examination. Primary patency, secondary patency, and limb salvage were defined according to the standards for reports of lower extremity ischemia suggested by Rutherford et al. ~I Primary patency was defined as any graft having continued function without procedures performed on the graft to maintain its function. Secondary patency was defined as any graft that required additional operations to maintain patency. Limb salvage was defined as the presence of a viable foot for walking even if a toe or transmetatarsal amputation was performed. Revision was defined as any operation to restore patency to a graft or to prevent eventual failure of a graft. Reoperation was any operation that resulted in replacement of most or all of the original graft. Data were stored on an IBM 381 mainframe computer. Statistical analysis was performed by one of us (M. S. R.), with software from Statistical Analysis Systems and consisted of X 2, life-table methods, and Cox proportional hazards linear regression. RESULTS The study group consisted of 46 patients who underwent 49 operations. The mean age of the patients was 64 years (range 6 to 79 years). Seventysix percent were men, 65 % were black, and 35% were white or Hispanic. Significant cardiovascular risk factors were prevalent, including diabetes in 76%, smoking in 62%, and hypertension in 69%. Symptomatic cardiac disease was present in 46% of patients and 23% of patients had a previous myocardial infarction. The indication for operation was claudication in one limb (2%), ischemic rest pain in six limbs (12%), and tissue loss in 42 limbs (86%). The operations included one above-knee popliteal-below-knee popliteal artery bypass, six distal superficial femoral artery-tibial artery bypasses, and 42 popliteal-tibial artery bypasses. Autogenous vein grafts included one reversed arm vein, five in situ saphenous veins, two composite leg vein grafts, and 41 reversed saphenous vein grafts. Bypass grafts originated from the distal superficial femoral artery in six cases (12%), the above-knee popliteal artery in 19 cases (39%), and the belowknee popliteal artery in 24 cases (49%). All patients had direct arterial pressure measurements at opera-
3 8 7 O 5 4 5O 2 Distal superficial femoral and popliteal to infragenicular bypass 693 \ oo 2o \.11 4, I ~ 72 MONIHS Fig. 2. Life-table plot of secondary patency for 49 infragenicular bypasses that originated from the distal superficial femoral or popliteal arteries. Number of patent grafts remaining at each interval is shown over the standard error for each interval. tion documenting normal inflow at the site of the proximal anastomosis. Distal anastomosis was performed to the below-knee popliteal artery in one case (2%), proximal tibial vessels in nine cases (18%), and distal tibial vessels in 39 cases (8%), including 18 bypasses to the dorsalis pedis artery. Runoff scores as calculated from preoperative arteriograms and operative prereconstruction arteriograms were 1. to 3.5 in 4% and 8.5 to in 6% of cases. There were no operative deaths. Twelve bypasses required intraoperatne revision, which included revision of the distal anastomosis, patch angioplasty, and graft thrombectomy. Follow-up extended to 72 months with a mean follow-up of 24 months. During this period, 2 patients died and were lost to follow-up. There were seven early (less than 3 days) and six late graft failures. Six grafts that failed early underwent thrombectomy and only two of these patients left the hospital with patent grafts. In addition to six late graft failures, two patent grafts had to be ligated for infection and two grafts were revised because of progressive inflow disease. The two patients who required inflow revision had patent grafts with evident progression ofstenosis in the superficial femoral artery as determined by noninvasive studies. One of these patients was lost to follow-up and one has a patent graft after revision. Life-table analysis showed a primary patency rate of 83% at 1 year, 62% at 3 years, and 41% at 5 years (Fig. 1). The secondary patency rate was 84% at 1 year, 62% at 3 years, and 42% at 5 years (Fig. 2). Cumulative limb salvage as calculated by life table was 69% at 6 years (Fig. 3). Cox proportional hazards linear regression analysis found that stenosis of 2% or more in the proximal superficial femoral artery, even with normal inflow pressure, was a significant risk factor for graft failure (p =.2), as was the severity of the runoff vessel disease (p =.4). Also tested in the proportional hazards model and found to be not significant were sex (p =.74), race (p =.8), diabetes (p =.35), smoking (p =.43), number of intraoperative revisions (p =.75), location of proximal anastomosis (p =.9), and location of distal anastomosis (p =.17). Life-table survival analysis revealed that only 24% of these patients were still alive at the end of 6 years (Fig. 4). Myocardial in:farction and stroke accounted for 35% and 15% of the deaths, respectively. DISCUSSION The early reports of infragenicular arterial reconstruction considered distal bypasses originating from the superficial femoral or popliteal arteries to have a higher risk of failure. 1'2,12aa However, these reports did not selectively evaluate the results of bypasses performed from vessels other than the common femoral artery. It was thought that these bypasses would fail because of progression of superficial femoral artery disease. 2 This belief was based on natural history studies that used serial arteriography to evaluate the progression of arterial disease in patients with claudication, a-s In particular, the likelihood of progression of superficial femoral artery disease as assessed by serial arteriogranas was found
4 694 Rosenbloom et al. Journal of VASCULAR SURGERY 8O 7O, I I.6, OO, MONTHS Fig. 3. Life-table plot of limb salvage for 48 limbs that underwent infragenicular bypasses originating from the distal superficial femoral or popliteal arteries. Number of limbs remaining at each interval is shown over the standard error for each interval. to be directly related to the degree of stenosis present on the first arteriogram2 Veith et al.8 compared the results of 419 popliteal and tibial bypasses originating from the common femoral artery with the results of 139 popliteal and tibial bypasses originating from the distal superficial femoral artery or popliteal artery. Similar secondary patency rates were achieved for bypasses that originated from the common femoral artery compared with those that originated from the distal superficial femoral artery or popliteal artery. The 6-year secondary patency rate for vein grafts to the popliteal artery was 89% for bypasses that originated from the distal superficial femoral artery or popliteal artery and 75% for bypasses that originated from the common femoral artery. Vein grafts to the infragenicular vessels had a 6-year secondary patency rate of 69% when originating from the superficial femoral and popliteal arteries. The 6-year secondary patency rate was 71% for infragenicular bypasses that originated from the common femoral artery. None of the 32 failures in 139 bypasses originating from the distal superficial femoral artery or popliteal artery was thought to be due to progression of stenosis in the superficial femoral artery. Our first report on this subject reported the results of 23 patients who had below-knee popliteal and tibial artery bypasses that originated from the distal superficial femoral artery or popliteal artery. 9 The secondary patency rate at 31 months was 84% with a limb salvage rate of 7%. There were ~w o cases of graft thrombosis, neither of which were related to the progression of stenosis in the superficial femoral artery. This report recommended the use of the superficial femoral artery or popliteal artery as the inflow source for infragenicular bypasses in patients having normal inflow to the popliteal artery and inadequate vein for a bypass from the common femoral artery. Cantelmo et al. 1 reported 1- and 3-year patency rates of 79% for distally based infragenicular bypasses. This report showed limb salvage rates of 89% at 1 year and 82% at 3 years. Feldman et al. 14 reported 11 bypasses from the below-knee popliteal artery to the distal tibial vessels. Two bypasses were immediate failures and nine remained patent for 2 to 48 months. These reports of grafts originating from the distal superficial femoral or popliteal arteries show that these bypasses can be performed with satisfactory patency and limb salvage. These reports cast doubt on the commonly held belief that progression of superficial femoral artery disease is inevitable and that such progression would lead to graft failure. In addition, there has been further evidence to suggest that shorter grafts may perform better than longer ones) sa6 The results of bypasses originating from the distal superficial femoral and popliteal arteries should be compared with the results of reversed saphenous vein bypasses and in situ saphenous vein bypasses origi-
5 Volume 7 Number 5 May 1988 Distal superficial femoral and popliteai to infragenicular bypass 695 8O 8.og MONTHS Fig. 4. Life-table plot of survival for 46 patients who underwent infragenicular bypasses originating from the distal superficial femoral and popliteal arteries. nating from the common femoral artery. Five-year patency and limb salvage rates with reversed saphenous vein bypass to the infragenicular vessels were respectively 55% and 73% as reported by Mannick, 17 46% and 6% as reported by Kacoyanis et al.,18 and 47% as reported by Reichle et al.19 Taylor et al.2.21 reported on the results of reversed vein bypasses including 38 bypasses to the tibial arteries that originated from the common femoral artery with a primary patency rate of 89% at 1 and 3 years. With the in situ saphenous vein technique, Corson et al. 22 reported 7% 3-year primary patency in 37 bypasses to ankle, foot, or discontinuous tibial vessels. Bandyk et al.23 reported 58% primary patency and 8% secondary patency for 128 femorotibial in situ saphenous vein grafts at 3 years. Fogle et al.24 compared in situ saphenous vein with reversed saphenous vein bypasses and found a 3-year patency rate of 87% for in situ saphenous vein grafts and 62% patency for reversed saphenous vein grafts. The early results of the present series are comparable to the results of both in situ and reversed saphenous vein bypasses. Although long-term patency is not so good as that found in other studies, the 5-year limb salvage rate was 69%. Significant risk factors for graft failure were stenosis in the superficial femoral artery of 2% or more at the time of bypass (p =.2) and the severity of disease in distal runoff vessels as measured by the runoff index (p =.4). The significance of 2% or more stenosis in the superficial femoral artery combined with documenta- tion of hemodynamically normal inflow at the proximal anastomsis of these bypasses at the time of operation leads us to speculate that progression of disease in the superficial femoral artery may occasionally result in graft: failure. An interesting finding was the high mortality rate in this group of patients, particularly from cardiovascular disease. This finding is in agreement with previous reports of patients having a distal pattern of atherosclerotic disease.25,26 The high mortality rate may have also adversely affected the patency rates for these bypasses in the life-table calculation. Infragenicular bypasses that originate from the distal superficial femoral or the popliteal artery can be performed with satisfactory pateney and limb salvage rates. Distally based bypasses provide a good alternative when the length of vein to be used for bypass is inadequate for anastomosis to the common femoral artery. Despite the apparent increased risk, we would still recommend that when there is not enough vein available to perform a long bypass, a distally based bypass should bc performed even in the presence of disease in the superficial femoral artery, provided the arterial pressure at the proximal anastomosis is systemic. Such a bypass, with autogenous vein used as a conduit, can be expected to have better patency and provide a higher limb salvage rate than longer prosthetic bypasses from the common femoral artery. This study cannot assess whether the common femoral or the popliteal artery used for graft origin is preferable when there is sufficient vein to
6 696 Rosenbloom et al perform either and there is less than 2% stenosis in the superficial femoral artery. REFERENCES 1. Garrett HE, Kotch PI, Green MT, Diethrich EB, DeBakey ME. Distal tibial artery bypass with autogenous vein grafts: an analysis of 56 cases. Surgery 1968;63:9. 2. Auer AL, Hershey FB. Bypass vein grafts to distal tibial or dorsalis pedis arteries. Mo Med 1973;7: Warren R, Gomez ILL, Marston JAP, Cox JST. Femoropopliteal arteriosclerosis obliterans: arteriographic patterns and rates of progression. Surgery 1964;55: Coran AG, Warren R. Arteriographic changes in femoropopliteal arteriosclerosis obliterans. N Engl J Med 1966; 274: Kuthan F, Burkhalter A, Baitsch R, Ludin H, Widmer LK. Development of occlusive arterial disease in lower limbs. Arch Surg 1971;3: Stabile BE, Wilson SE. The profunda femoris-popliteal artery bypass. Arch Surg 1977;112: Buxton B, Reeves L, Roberts AK. Distal profunda femoris to popliteal artery bypass for patients with a short length of long saphenous vein. Surgery 1978;83: Veith FJ, Gupta SK, Samson RH, Flores SW, Janko G, Scher LA. Superficial femoral and popliteal arteries as inflow sites for distal bypasses. Surgery 1981;9: Schuler JJ, Flanigan DP, Williams LR, Ryan TJ, Castronnovo JJ. Early experience with popliteal to infragenicular bypass for limb salvage. Arch Surg 1983;118:472.. Cantelmo NL, Snow JR, Menzoian J'O, LoGerfo FW. Successful vein bypass in patients with an ischemic limb and a palpable popliteal pulse. Arch Surg 1986;121: Rutherford RB, Flanigan DP, Gupta SK, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vase SURG 1986;4: Garrett HE, De Bakey ME. Distal posterior tibia] artery bypass with autogenous vein graft: a report of three cases. Surgery 1966;6: Shieber W, Parks C. Dorsalis pedis artery in bypass grafting. Am J Surg 1974;128: Feldm_an AJ, Nevonen M, Berguer R. Experience with popliteai-inftapopliteal bypass grafting. Surg Gynecol Obstet 1982;154: Veith FJ, Ascer E, Gupta SK, et al Tibiotibial vein bypass grafts: a new operation for limb salvage. J Vase SURG 1985;2: Ascer E, Veith FJ, Gupta SK, White SA, Bakal CW, Wengetter K, Sprayregen S. Short vein grafts: a superior option for arterial reconstructions to poor or compromised outflow tracts' J VASC SURG 1988;7: Mannick JA. Femoro-popliteal and femoro-tibial reconstructions. Surg Clin North Am 1979;59: Kacoyanis GP, Whittemore AD, Couch NP, Mannick JA. Femorotibial and femoroperoneal bypass vein grafts. Arch Surg 1981;116: Reichle FA, Rankin KP, Tyson RR, Finestone AJ, Shuman C. Long,term results of 474 arterial reconstructions for severely ischemic limbs: a fourteen-year follow-up. Surgery, 1979;85: Taylor LM, Phinney ES, Porter IM. Present status of reversed vein bypass for lower extremity revascularization. J Vase SURG 1986;3: Taylor LM, Edwards JM, Phinney ES, Porter JM. Reversed vein bypass to infrapopliteal arteries. Ann Surg 1987;25: Corson ID~ Karmody AM, Shah DM, Naraynsingh V, Young HL, Leather RP. In situ vein bypasses to distal tibial and limited outflow tracts for limb salvage. Surgery 1984;96: Bandyk DF, Kaebnick HW, Stewart GW, Towne lb. Durability of the in sire saphenous vein arterial bypass: a comparison of primary and secondary patency. J VAse SUP,6 1987;5: Fogle/VIA, Whittemore AD, Couch NP, Mannick JA. A comparison of in situ and reversed saphenous vein grafts for infrainguinal reconstruction. J VASe SURG 1987;5: Martinez BD, Hertzer NR, Beven EG. Influence of distal arterial occlusive disease on prognosis following aortobifemoral bypass. Surgery 198;88: Kallero KS, Bergqvist D, Cederholm C, Jonsson K, Olsson PO, Takolander R. Arteriosclerosis in popliteal artery trifurcation as a predictor for myocardial infarction after arterial reconstructive operation. Surg Gynecol Obstet 1984;159: 133.
Influence of vein size (diameter) on infrapopliteal reversed vein graft patency
Influence of vein size (diameter) on infrapopliteal reversed vein graft patency Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushil K. Gupta, MD, Enrico Ascer, MD, and Steven P. Rivers, MD, New York, N.Y.
More informationPopliteal-to-distal bypass for limb-threatening ischemia
Popliteal-to-distal bypass for limb-threatening ischemia Jeffrey Marks, MD, Terry A, King, MD, Henry Baele, MD, Jeffrey Rubin, MD, and Cynthia Marmen, RN, Cleveland, Ohio In a subset of patients requiring
More informationEleven-year experience with tibiotibial bypass: An unusual but effective solution distal tibial artery occlusive disease and limited autologous vein
Eleven-year experience with tibiotibial bypass: An unusual but effective solution distal tibial artery occlusive disease and limited autologous vein to Ross T. Lyon, MD, Frank J. Veith, MD, Ben U. Marsan,
More informationThe long-term value of composite limb salvage
The long-term value of composite limb salvage grafts for John B. Chang, MD, and Theodore A. Stein, PhD, Roslyn, N.Y. Purpose: We determined the long-term efficacy of composite grafts for limb salvage when
More informationExposure of the anterior tibial artery by medial popliteal extension
Exposure of the anterior tibial artery by medial popliteal extension J. G. Sladen, FRCS(C), G. Kougeer, FRCS(C), and J. D. S. Reid, FRCS(C), Vancouver) British Columbia) Canada This report describes exploration
More informationEfficacy of the dorsal pedal salvage in diabetic patients: Short-term observations. bypass for limb
Efficacy of the dorsal pedal salvage in diabetic patients: Short-term observations bypass for limb Frank B. Pomposelli, Jr., MD, Stephen J. Jepsen, MD, Gary W. Gibbons, MD, David R. Campbell, MD, Dorothy
More informationThe use of spliced vein bypasses for infrainguinal arterial reconstruction
The use of spliced vein bypasses for infrainguinal arterial reconstruction Benjamin B. Chang, MD, R. Clement Darling III, MD, Devon E. M. Bock, MD, Dhiraj M. Shah, MD, and Robert P. Leather, MD, Albany,
More informationPedal or peroneal bypass: Which is better when both are patent?
Pedal or peroneal bypass: Which is better when both are patent? Thomas M. Bergamini, MD, Salem M. George, Jr., MD, H. Todd Massey, MD, Peter K. Henke, MD, Thomas W. Klamer, MD, Glenn E. Lambert, Jr., MD,
More informationJohn E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationLower-Extremity Revascularization
Lower-Extremity Revascularization The open approach to treating limb-threatening lower-extremity ischemia has proven to be an effective means of achieving revascularization. BY RICHARD F. NEVILLE, MD,
More informationA comparison of in situ and saphcnous vein grafts for infrainguinal reconstruction. reversed
A comparison of in situ and saphcnous vein grafts for infrainguinal reconstruction reversed Martin A. Fogle, M.D., Anthony D. Whittemore, M.D., Nathan P. Couch, M.D., and John A. Mannick, M.D., Boston,
More informationDistal By-Pass procedures can reduce limb loss
Conventional treatment of the diabetic foot Distal By-Pass procedures can reduce limb loss Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department of Surgery,
More informationStratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery
More informationEndovascular Should Be Considered First Line Therapy
Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach
More informationVasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania
ENDOVASCULAR TREATMENT FOR VASCULAR GRAFT RESTENOSIS Bogdan Totolici 1, Francisca Blanca Călinescu 1*, Ionel Droc 2, Carmen Neamţu 1 1 Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy
More informationIs the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?
Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? William J. Quifiones-Baldrich, MD, Ronald W. Busuttil, MD, PhD, J. Dennis Baker, MD, Candace L. Vescera,
More informationFOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in
11 Evaluation and Management of Peripheral Arterial Disease Joseph L. Mills, Sr., MD FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in the United States, foot problems ulceration, infection, and
More informationShort-term and midterm results of an all-autogenous tissue policy for infrainguinal reconstruction
Short-term and midterm results of an all-autogenous tissue policy for infrainguinal reconstruction K. Craig Kent, MD, Anthony D. Whittemore, MD, and John A. Mannick, MD, Boston, Mass. Saphenous vein is
More informationPrediction of early graft failure with intraoperative completion duplex ultrasound scan
Prediction of early graft failure with intraoperative completion duplex ultrasound scan Eva M. Rzucidlo, MD, Daniel B. Walsh, MD, Richard J. Powell, MD, Robert M. Zwolak, MD, PhD, Mark F. Fillinger, MD,
More informationDistal revascularization and microvascular
Distal revascularization and microvascular free tissue transfer: An alternative to amputation in ischemic lesions of the lower extremity Susan E. Briggs, M.D., Joseph C. Banis, Jr., M.D., Hermann Kaebnick,
More informationAxillopopliteal bypass grafting: Indications, late results, and determinants of long-term patency
Axillopopliteal bypass grafting: Indications, late results, and determinants of long-term patency Enrico Ascer, MD, FACS, Frank J. Veith, MD, FACS, and Sushil Gupta, MD, FACS, New York, N.Y. In the last
More informationAutogenous composite vein bypass graft for infrainguinal arterial reconstruction
Autogenous composite vein bypass graft for infrainguinal arterial reconstruction David K. W. Chew, MD, Michael S. Conte, MD, Magruder C. Donaldson, MD, Anthony D. Whittemore, MD, John A. Mannick, MD, and
More informationLong-term assessment of cryopreserved vein bypass grafting success
Long-term assessment of cryopreserved vein bypass grafting success Linda Harris, MD, a Monica O Brien-Irr MS, RN, a and John J. Ricotta, MD, b Buffalo, NY Purpose: When autogenous vein is unavailable,
More informationChronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis
Chronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis JAMIE D. SANTILLI, M.D., and STEVEN M. SANTILLI, M.D., PH.D. University of Minnesota School of Medicine Minneapolis, Minnesota Chronic
More informationA new method for the prediction of peripheral vascular resistance from the preoperative angiogram
A new method for the prediction of peripheral vascular resistance from the preoperative angiogram Wayne W. LaMorte, M.D., James O. Menzoian, M.D., Anton Sidawy, M.D., and Timothy Heeren, Ph.D., Boston,
More informationCombat Extremity Vascular Trauma
Combat Extremity Vascular Trauma Training teams to be a TEAM Chatt A. Johnson LTC, MC, USA 08 March 2010 US Army Trauma Training Center Core Discussion Series Outline: Combat Vascular Injury Physiologic
More informationNon-invasive examination
Non-invasive examination Segmental pressure and Ankle-Brachial Index (ABI) The segmental blood pressure (SBP) examination is a simple, noninvasive method for diagnosing and localizing arterial disease.
More informationComparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting
International Journal of Surgery (2007) 5, 109e113 www.theijs.com Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting A. Mohammadi Tofigh a,
More informationSurgery is and Remains the Gold Standard for Limb-Threatening Ischemia
Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you
More informationPractical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
More informationSurgical Options for revascularisation P E T E R S U B R A M A N I A M
Surgical Options for revascularisation P E T E R S U B R A M A N I A M The goal Treat pain Heal ulcer Preserve limb Preserve life The options Conservative Endovascular Surgical bypass Primary amputation
More informationLateral approach to the popliteal artery
Lateral approach to the popliteal artery Frank J. Veith, M.D., Enrico Ascer, M.D., Sushil K. Gupta, M.D., and Kurt R. Wengerter, M.D., New York, N.Y. Techniques for exposure of the popliteal artery via
More informationDisclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009
Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting
More informationVascular claudication: How to individualize treatment
REVIEW BRUCE H. GRAY, DO Codirector, Peripheral Interventional Laboratory, Cleveland Clinic. TIMOTHY M. SULLIVAN, MD Codirector, Peripheral Interventional Laboratory, Cleveland Clinic. Vascular claudication:
More informationClinical and social consequences of Buerger disease
Clinical and social consequences of Buerger disease Takashi Ohta, MD, Hiroyuki Ishioashi, MD, Minoru Hosaka, MD, and Ikuo Sugimoto, MD, Aichi, Japan Purpose: This study was undertaken to assess the clinical
More informationPAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare
More informationAxillobrachial artery bypass grafting with in situ cephalic vein for axillary artery occlusion: A case report
CASE REPORTS Axillobrachial artery bypass grafting with in situ cephalic vein for axillary artery occlusion: A case report Evan S. Cohen,/VII), Robert B. Holtzman, MD, and George W. Johnson, Jr., MD, Houston,
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationImpact of a color-flow duplex surveillance program on infrainguinal vein graft patency: A five-year experience
Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: A five-year experience Mirza M. Idu, MD, Jan D. Blankenstein, MD, PhD, Peter de Gier, MD, Elly Truyen, RVT, and Jacob
More informationRemote Endarterectomy Update
Remote Endarterectomy Update An endovascular alternative to bypass? BY JOHN D. MARTIN, MD Treating the superficial femoral artery (SFA) is still one of the most highly debated topics among vascular specialists.
More informationGerald S. Treiman, MD, Amir Ashrafi, and Peter F. Lawrence, MD, Salt Lake City, Utah
Incidentally detected stenoses proximal to grafts originating below the common femoral artery: Do they affect graft patency or warrant repair in asymptomatic patients? Gerald S. Treiman, MD, Amir Ashrafi,
More informationDistal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff
Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff P. Kuryanov, A. Lipin, A. Antropov, K. Atmadzas, A. Atmadzas, Y. Eminov, A. Borisov, R. Sobolev, A.Orlov Limb
More informationDurability of vein graft revision: The outcome of secondary procedures
Durability of vein graft revision: The outcome of secondary procedures Dennis F. Bandyk, MD, Thomas M. Bergamini, MD, Jonathan B. Towne, MD, David D. Schmitt, MD, and Gary R. Seabrook, MD, Milwaukee, Wis.
More informationThe posterior approach to popliteal-crural bypass
The posterior approach to popliteal-crural bypass Kenneth Ourie1, MD, Rochester) N. Y. Purpose: An evaluation of the posterior approach to popliteal-crural bypass was performed to assess the feasibility
More informationInfrainguinal vein bypass graft revision: Factors affecting long-term outcome
From the Society for Vascular Surgery Infrainguinal vein bypass graft revision: Factors affecting long-term outcome Louis L. Nguyen, MD, MBA, Michael S. Conte, MD, Matthew T. Menard, MD, Edwin C. Gravereaux,
More informationCase Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN
Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center
More informationArthroplasty after previous surgery: previous vascular problems
Arthroplasty after previous surgery: previous vascular problems Jacques Menetrey & Victoria B. Duthon Centre de médecine de l appareil locomoteur et du sport Swiss Olympic medical Center Unité d Orthopédie
More informationResident Teaching Conference 3/12/2010
Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute
More informationPeripheral Vascular Disease
Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of
More informationLong-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal failure
Long-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal failure Shari L. Meyerson, MD, Christopher L. Skelly, MD, Michael A. Curi, MD, MPA, Tina R. Desai, MD,
More informationPopliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS
Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS Asymptomatic mass - 38-40%will develop symptoms at a rate of 14%/yr Intermittent claudic ation (chronic ischemia) - 25%-40%
More informationProsthetic graft placement and creation of a distal arteriovenous fistula for secondary vascular reconstruction in patients with severe limb ischemia
Prosthetic graft placement and creation of a distal arteriovenous fistula for secondary vascular reconstruction in patients with severe limb ischemia Michael J. H. M. Jacobs, MD, Igor D. Gregoric, MD,
More informationThe ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions
The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker
More informationDisclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are
An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical
More informationDiagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,
More informationOptimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy
From the Southern Association for Vascular Surgery Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,
More informationSerial hemodynamic assessment of aortobifemoral bypass
Serial hemodynamic assessment of aortobifemoral bypass Robert B. Rutherford, M.D., Darrell N. Jones, Ph.D., M. Scott Martin, M.S., Richard F. Kempczinski, M.D., and Robert D. Gordon, M.D., Denver, Colo.,
More informationNational Vascular Registry
National Vascular Registry Angioplasty Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or
More informationCurrent Vascular and Endovascular Management in Diabetic Vasculopathy
Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery
More informationThe lesser saphenous vein: Autogenous tissue for lower extremity revascularization
The lesser saphenous vein: Autogenous tissue for lower extremity revascularization Fred A. Weaver, M.D., C. Robert Barlow, M.D., William H. Edwards, M.D., Joseph L. Mulherin, Jr., M.D., and Judith M. Jenkins,
More informationInfrainguinal bypass grafting in patients with endstage renal disease: Improving outcomes?
Infrainguinal bypass grafting in patients with endstage renal disease: Improving outcomes? John C. Lantis II, MD, Michael S. Conte, MD, Michael Belkin, MD, Anthony D. Whittemore, MD, John A. Mannick, MD,
More informationProspective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses
Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushi/K. Gupta, MD, Jamie Goldsmith, RN, Elizabeth FarreU,
More informationLimb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017
Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene
More informationCritical Limb Ischemia: Diagnosis and Current Management
Research Article Joseph Karam, MD Elliot J. Stephenson, MD From: Minneapolis Heart Institutet at Abbott Northwestern Hospital, Minneapolis, MN Address for correspondence: Joseph Karam, MD Minneapolis Heart
More informationResults of a policy with arm veins used as the first alternative to an unavailable ipsilateral greater saphenous vein for infrainguinal bypass
Results of a policy with arm veins used as the first alternative to an unavailable ipsilateral greater saphenous vein for infrainguinal bypass Thomas J. H61zenbein, MD, Frank B. Pomposelli, Jr., MD, Arnold
More informationOptimal conduit choice in the absence of singlesegment great saphenous vein for below-knee popliteal bypass
From the Society for Vascular Surgery Optimal conduit choice in the absence of singlesegment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD, C. Keith Ozaki,
More informationLower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4
Lower Extremity Revascularization D oes Anesthesia Matter Onaona Gurney PGY 4 Case Presentation 89yoM PMH of HTN, DM, HLD, BPH presented to podiatry with abscess to R great toe 5 weeks prior Drained by
More informationN. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia
Duplex scan surveillance prosthetic bypass grafts of infrainguinal N. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia Purpose: Surveillance
More informationTHE popliteal artery is the second most common site of aneurysm. The
POPLITEAL ANEURYSM Treatment by Vein Graft: Case Report A. W. HUMPHRIES, M.D. Department of Orthopedic Surgery F. A. LeFEVRE, M.D. and V. G. dewolfe, M.D. Department of Cardiovascular Disease THE popliteal
More informationPractical Point in Diabetic Foot Care 3-4 July 2017
Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University
More informationA Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006
A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts Avishai Meyer UCHSC resident, Surgery May 8, 2006 Outline: Definition Background of terms and studies U/S surveillance What
More informationImaging Strategy For Claudication
Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon
More informationIsolated femoral endarterectomy: Impact of SFA TASC classification on recurrence of symptoms and need for additional intervention
From the Eastern Vascular Society Isolated femoral endarterectomy: Impact of SFA TASC classification on recurrence of symptoms and need for additional intervention Georges Al-Khoury, MD, Luke Marone, MD,
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/30/2012 Radiology Quiz of the Week # 79 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationPeter A. Schneider, MD, Michael T. Caps, MD, MPH, Darren Y. Ogawa, RVT, and Eric S. Hayman, PA-C, Honolulu, Hawaii
Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: An option for combined open and endovascular treatment of diabetic gangrene Peter A. Schneider, MD, Michael
More informationNational Vascular Registry
National Vascular Registry Bypass Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or postcode.
More informationA comparative study of alternative conduits for lower extremity revascularization: Allautogenous conduit versus prosthetic grafts
A comparative study of alternative conduits for lower extremity revascularization: Allautogenous conduit versus prosthetic grafts Peter L. Faries, MD, a Frank W. LoGerfo, MD, b Subodh Arora, MD, b Shannon
More informationLIMB SALVAGE IN THE DIABETIC PATIENT
LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? DISCLOSURES Educational grant from Cook Inc OBJECTIVES Review risk stratification and staging schemes for the threatened limb Discuss current concepts
More informationDuplex Scanning or Arteriography for Preoperative Planning of Lower Limb Revascularisation
Eur J Vasc Endovasc Surg 24, 3±36 (2002) doi:0.053/ejvs.2002.623, available online at http://www.idealibrary.com on Duplex Scanning or Arteriography for Preoperative Planning of Lower Limb Revascularisation
More informationThe present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio
The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have
More information4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider
Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes Lower Extremity Revascularization Options: Key Factors to Consider General health of the patient Michael S. Conte MD Division of Vascular
More informationAb H. Boontje, M.D., Ph.D., Groningen, Holland
Aneurysm formation in human umbilical vein grafts used as arterial substitutes Ab H. Boontje, M.D., Ph.D., Groningen, Holland A series of 257 human umbilical vein grafts for femoropopliteal bypass in 203
More informationThe variation in vein graft flow velocity luminal diameter and outflow level
The variation in vein graft flow velocity luminal diameter and outflow level with Michael Belkin, MD, William C. Mackey, MD, Robert McLaughlin, BS, RVT, Susan B. Umphrey, RVT, and Thomas F. O'Donnell,
More informationInfluence of the profunda femoris vein on venous hemodynamics of the limb
Influence of the profunda femoris vein on venous hemodynamics of the limb Experience from thirty-one deep vein valve reconstructions Ingvar Eriksson, M.D., and Bo Almgren, M.D., Uppsala, Sweden Venous
More informationComparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.1.28 Annals of Surgical Treatment and Research Comparison of long-term results of above-the-knee femoro-popliteal
More informationAcute arterial complications associated with total hip and knee arthroplasty
From the Eastern Vascular Society Acute arterial complications associated with total hip and knee arthroplasty Keith D. Calligaro, MD, a Matthew J. Dougherty, MD, a Sean Ryan, MD, a and Robert E. Booth,
More informationAngioplasty of the tibioperoneal vessels has had limited
Tibioperoneal (Outflow Lesion) Angioplasty Can Be Used as Primary Treatment in 235 Patients With Critical Limb Ischemia Five-Year Follow-Up Gerald Dorros, MD; Michael R. Jaff, DO; Ari M. Dorros, MD; Lynne
More informationCritical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017
Critical Limb Ischemia A Collaborative Approach to Patient Care Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Surgeons idea Surgeons idea represents the final stage of peripheral
More informationSAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS
SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS LIBBY WATCH, MD MIAMI VASCULAR SPECIALISTS MIAMI CARDIAC & VASCULAR INSTITUTE FINANCIAL DISCLOSURES None 2
More informationAsymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses
Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses R. James Valentine, MD, John D. Martin, MD, Smart I. Myers, MD, Matthew
More informationRecommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines
Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular
More informationDCB in my practice: How the evidence influences my strategy. Yang-Jin Park
DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of
More informationPUT YOUR BEST FOOT FORWARD
PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.
More informationSurgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert
LINC 2016, Leipzig Surgical Bypass or A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist Wouter Van den Eynde OLV Hospital,
More informationPedal Bypass With Deep Venous Arterialization:
Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj
More informationJ. G. Sladen, MD, J. D. S. Reid, MD, T. M. Maxwell, MD, and A. R. Downs, MD, Vancouver, British Columbia, and Winnipeg, Manitoba, Canada
Superficial femoral vein: harvest site A useful autogenous J. G. Sladen, MD, J. D. S. Reid, MD, T. M. Maxwell, MD, and A. R. Downs, MD, Vancouver, British Columbia, and Winnipeg, Manitoba, Canada Purpose:
More informationPosterior Exposure of the Popliteal Artery in Reoperative Vascular Surgery
Vol. 10, No. 1 1996 Case reports 53 sible, removal of the intact filter should be attempted with a square retrieval device. It should be clear that patients with vena cava filters should not undergo "routine"
More information